Clinical Report: Purely Refractive IOL Demonstrates Good Results in Eyes with Ocular Comorbidities
Overview
A retrospective analysis of 418 patients with ocular comorbidities showed that those implanted with bilateral Tecnis PureSee IOLs achieved excellent distance and good intermediate vision, along with functional near vision.
Background
The management of patients with ocular comorbidities seeking refractive lens exchange (RLE) poses unique challenges in achieving optimal visual outcomes. Understanding the performance of intraocular lenses (IOLs) in this patient population is crucial for improving visual quality and patient satisfaction. The Tecnis PureSee IOL, with its non-diffractive design, aims to balance visual acuity and minimize dysphotopsia.
Data Highlights
| Visual Acuity | Distance (logMAR) | Intermediate (logMAR) | Near (logMAR) |
|---|---|---|---|
| Mean Uncorrected Binocular Visual Acuity | -0.002 | 0.131 | 0.224 |
| Proportion of Patients (≥0.20 logMAR) | 95.7% | 78.0% | 45.5% |
Key Findings
- Patients achieved a mean uncorrected binocular visual acuity of -0.002 logMAR at distance.
- At two months post-RLE, 95.7% of patients had a distance visual acuity of 0.20 logMAR or better.
- Near vision was most affected in patients with macular disease, with 45.5% achieving 0.20 logMAR or better.
- The PureSee IOL's non-diffractive design preserves contrast sensitivity and reduces the incidence of bothersome halos.
- A mild monovision strategy can enhance functional near vision while maintaining good distance and intermediate performance.
Clinical Implications
Clinicians should provide thorough counseling to patients with ocular comorbidities regarding realistic expectations for visual outcomes post-RLE.
Conclusion
The Tecnis PureSee IOL demonstrates good visual outcomes while addressing the challenges of spectacle independence.
Related Resources & Content
- Ophthalmology Management, 2025 -- Purely Refractive EDOF IOL Reduces Spectacle Dependence
- Ophthalmology Management, 2021 -- How to utilize premium IOLs
- Corneal Physician, 2022 -- Selecting an IOL
- ScienceDirect -- Recommendation for Presbyopia-Correcting Intraocular Lenses: A Delphi Consensus Statement by the ESASO Study Group
- Johnson & Johnson, 2026 -- Clinical Data for TECNIS PureSee IOL
- The Ophthalmologist, 2026 -- Purely Refractive IOL Demonstrates Good Results in Eyes with Ocular Comorbidities
- Ophthalmology Management — IOL psychology
- Recommendation for Presbyopia-Correcting Intraocular Lenses: A Delphi Consensus Statement by the ESASO Study Group - ScienceDirect
- Johnson & Johnson Showcases New Clinical Data for TECNIS PureSee IOL at ASCRS 2026 Demonstrating Excellent Contrast Sensitivity and Extended Range of Vision | J&J MedTech US
- The Ophthalmologist | Purely Refractive IOL Demonstrates Good Results in Eyes with Ocular Comorbidities
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.